BioNTech CEO Sahin reports 63,209-share sale
BioNTech CEO Ugur Sahin reported selling 63,209 shares of BioNTech SE at $94.07 apiece in a Form 4 filing. The filing says the transaction was made under a 10b5-1 plan.
Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
1 result loaded, newest first. End of these results.
BioNTech CEO Ugur Sahin reported selling 63,209 shares of BioNTech SE at $94.07 apiece in a Form 4 filing. The filing says the transaction was made under a 10b5-1 plan.